Table 5.

Maintenance immunosuppression among kidney transplant recipients with and without severe acute respiratory syndrome coronavirus 2 while an inpatient

Immunosuppression	Total, N=256, n (%)	Kidney Transplant Recipients		P value
		Severe Acute Respiratory Syndrome Coronavirus 2 Positive, N=32, n (%)	Severe Acute Respiratory Syndrome Coronavirus 2 Negative, N=224, n (%)
Tacrolimus	195 (76)	27 (84)	168 (75)	0.24
Belatacept	16 (6)	2 (6)	14 (6)	1.00
Cyclosporine	12 (5)	1 (3)	11 (5)	0.66
Sirolimus	7 (3)	0 (0)	7 (3)	0.60
Everolimus	5 (2)	0 (0)	5 (2)	1.00
Mycophenolate	152 (59)	11 (34)	141 (63)	0.002
Azathioprine	14 (5)	2 (6)	12 (5)	0.69
Steroids	219 (86)	26 (81)	193 (86)	0.46

P values were obtained using the Kruskal-Wallis test. Values in red represent statistically significant differences. Fisher’s exact test was used for comparison in cells with < five participants.